Home Genetic Testing Kits: Not What the Doctor Ordered

- Majority of physicians are not likely to recommend home testing kits to patients -

FLEMINGTON, N.J., May 13 /PRNewswire/ -- Results of a new national media study among 693 physicians revealed that the majority of physicians (71%) reported that it is not appropriate for pharmacies to sell home genetic testing kits.

(Logo:  http://www.newscom.com/cgi-bin/prnh/20071204/NYTU133LOGO )

The study was conducted during May 12-13 by HCD Research using its MediaCurves.com® website, to obtain physicians' perceptions of a news report that Walgreens pharmacies will sell home genetic testing kits that assess the risk of developing dozens of health conditions, including Alzheimer's disease, breast cancer and heart disease. To view detailed results go to: www.mediacurves.com.

The majority of physicians (59%) also indicated that results from a home genetic test kit would have no impact on their treatment plans for patients. In addition, a clear majority of physicians (80%) reported that they were either "somewhat unlikely" or "extremely unlikely" to recommend the purchase of home genetic testing kits to their patients.

Among the findings:

Is it appropriate for pharmacies to sell a home genetic testing kit?






Would test results from a home genetic test kit have an impact on your treatment plans for patients?






How likely are you to recommend the purchase of home genetic testing kits to patients?


Extremely likely


Somewhat likely


Somewhat unlikely


Extremely unlikely


HCD Research is a marketing and communications research company headquartered in Flemington, NJ.  The company's services include traditional and web-based research.  For additional information on HCD Research, access the company's web site at www.hcdi.net or call HCD Research at 908-788-9393. MediaCurves.com® (www.mediacurves.com) is a media measurement website that provides the media and general public with a venue to view Americans' perceptions of popular and controversial media events and advertisements.

SOURCE HCD Research, Inc.

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.